Compare · CDXS vs DD
CDXS vs DD
Side-by-side comparison of Codexis Inc. (CDXS) and DuPont de Nemours Inc. (DD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDXS and DD operate in Major Chemicals (Industrials), so they compete in similar markets.
- DD is the larger of the two at $19.26B, about 81.3x CDXS ($236.8M).
- DD has been more active in the news (18 items in the past 4 weeks vs 1 for CDXS).
- DD has more recent analyst coverage (25 ratings vs 12 for CDXS).
- Company
- Codexis Inc.
- DuPont de Nemours Inc.
- Price
- $2.60+2.36%
- $46.97+0.28%
- Market cap
- $236.8M
- $19.26B
- 1M return
- +0.39%
- -
- 1Y return
- +9.01%
- -
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2010
- 2017
- News (4w)
- 1
- 18
- Recent ratings
- 12
- 25
Codexis Inc.
Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
DuPont de Nemours Inc.
DuPont de Nemours, Inc. provides technology-based materials, ingredients, and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. The company's Electronics & Imaging segment supplies materials to manufacture photovoltaics and solar cells; materials and printing systems to the advanced printing industry; and materials and solutions for the fabrication of semiconductors and integrated circuits addressing front-end and back-end of the manufacturing process. This segment also provides semiconductor and advanced packaging materials; dielectric and metallization solutions for chip packaging; and silicones for light emitting diode packaging and semiconductor applications; permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, electroless, and electrolytic metallization solutions, as well as patterning solutions, and materials and metallization processes for metal finishing, decorative, and industrial applications. In addition, it offers various materials to manufacture rigid and flexible displays for liquid crystal displays, advanced-matrix organic light emitting diode, and quantum dot applications. The Transportation & Advanced Polymers segment provides engineering resins, adhesives, silicones, lubricants, and parts to engineers and designers in the transportation, electronics, healthcare, industrial, and consumer end-markets. Its Safety & Construction segment provides engineered products and integrated systems for worker safety, water purification and separation, aerospace, energy, medical packaging, and building materials. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. is based in Wilmington, Delaware.
Latest CDXS
- Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
- SEC Form 10-Q filed by Codexis Inc.
- Codexis Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- Codexis Reports First Quarter 2026 Financial Results
- Codexis to share RNA manufacturing advances at TIDES USA
- SEC Form DEFA14A filed by Codexis Inc.
- SEC Form DEF 14A filed by Codexis Inc.
- Codexis to Report First Quarter 2026 Financial Results on May 7
- SEC Form 8-K filed by Codexis Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Codexis Inc.
Latest DD
- CEO Koch Lori covered exercise/tax liability with 4,673 shares and sold $12,741 worth of shares (261 units at $48.82), decreasing direct ownership by 1% to 345,172 units (SEC Form 4)
- SVP & CFO Franzen Antonella B covered exercise/tax liability with 1,558 shares, decreasing direct ownership by 2% to 68,809 units (SEC Form 4)
- Director Macpherson Donald G was granted 671 shares, increasing direct ownership by 13% to 5,868 units (SEC Form 4)
- Director Lowery Frederick M. was granted 800 shares, increasing direct ownership by 2% to 40,205 units (SEC Form 4)
- Director Cutler Alexander M was granted 1,033 shares, increasing direct ownership by 1% to 81,794 units (SEC Form 4)
- SEC Form SD filed by DuPont de Nemours Inc.
- Director Breen Edward D was granted 4,030 shares, increasing direct ownership by 1% to 278,008 units (SEC Form 4)
- Director Macpherson Donald G was granted 4,030 shares, increasing direct ownership by 345% to 5,197 units (SEC Form 4)
- Director Mcmaken Kurt B was granted 4,030 shares, increasing direct ownership by 95% to 8,258 units (SEC Form 4)
- Director Lowery Frederick M. was granted 4,030 shares, increasing direct ownership by 11% to 39,405 units (SEC Form 4)